In the latest session, Adicet Bio Inc (NASDAQ: ACET) closed at $2.00 down -2.44% from its previous closing price of $2.05. In other words, the price has decreased by -$0.0500 from its previous closing price. On the day, 5371157 shares were traded.
Ratios:
For a deeper understanding of Adicet Bio Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.40 and its Current Ratio is at 9.40. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
JP Morgan Downgraded its Overweight to Neutral on June 01, 2023, whereas the target price for the stock was revised from $20 to $6.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 25 ’24 when ORBIMED ADVISORS LLC bought 3,125,000 shares for $2.40 per share. The transaction valued at 7,500,000 led to the insider holds 7,526,359 shares of the business.
GORDON CARL L bought 3,125,000 shares of ACET for $7,500,000 on Jan 25 ’24. The Director now owns 7,526,359 shares after completing the transaction at $2.40 per share. On Oct 02 ’23, another insider, Schor Chen, who serves as the President & CEO of the company, bought 5,500 shares for $1.33 each. As a result, the insider paid 7,340 and bolstered with 43,469 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACET now has a Market Capitalization of 165.00M and an Enterprise Value of 3.54M. Its current Enterprise Value per Revenue stands at 2.14 whereas that against EBITDA is -0.03.
Stock Price History:
Over the past 52 weeks, ACET has reached a high of $7.89, while it has fallen to a 52-week low of $1.10. The 50-Day Moving Average of the stock is 2.6895, while the 200-Day Moving Average is calculated to be 2.3096.
Shares Statistics:
For the past three months, ACET has traded an average of 1.64M shares per day and 2.01M over the past ten days. A total of 82.05M shares are outstanding, with a floating share count of 65.39M. Insiders hold about 20.31% of the company’s shares, while institutions hold 43.11% stake in the company. Shares short for ACET as of Feb 29, 2024 were 5.66M with a Short Ratio of 3.44, compared to 3.89M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 6.90% and a Short% of Float of 7.99%.
Earnings Estimates
There are 8 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.69 for the current quarter, with a high estimate of -$0.45 and a low estimate of -$0.78, while EPS last year was -$0.72. The consensus estimate for the next quarter is -$0.58, with high estimates of -$0.28 and low estimates of -$0.78.
Analysts are recommending an EPS of between -$3.09 and -$3.41 for the fiscal current year, implying an average EPS of -$3.32. EPS for the following year is -$2.44, with 8 analysts recommending between -$1.13 and -$3.44.
